122 related articles for article (PubMed ID: 32415722)
61. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
[TBL] [Abstract][Full Text] [Related]
62. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma.
Salajegheh A; Vosgha H; Rahman MA; Amin M; Smith RA; Lam AK
Hum Pathol; 2016 May; 51():75-85. PubMed ID: 27067785
[TBL] [Abstract][Full Text] [Related]
63. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
64. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
Wang LL; Zhang M
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321
[TBL] [Abstract][Full Text] [Related]
65. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
66. [Expression of microRNA-155 in papillary thyroid carcinoma and its clinical significance].
Zhu YZ; Zheng K; Zhang HH; Chen L; Wu KL; Ren CH; Wang ZC; Kong LJ; Ruan WH; Chen XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1364-1368. PubMed ID: 27777199
[TBL] [Abstract][Full Text] [Related]
67. A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma.
Wang X; Huang S; Li X; Jiang D; Yu H; Wu Q; Gao C; Wu Z
PLoS One; 2018; 13(7):e0200290. PubMed ID: 30005075
[TBL] [Abstract][Full Text] [Related]
68. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
[TBL] [Abstract][Full Text] [Related]
69. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
72. Expression of MicroRNAs in Thyroid Carcinoma.
Zhu G; Xie L; Miller D
Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
[TBL] [Abstract][Full Text] [Related]
73. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
74. Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z
J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351
[TBL] [Abstract][Full Text] [Related]
75. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
Shen N; Huang X; Li J
Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
[TBL] [Abstract][Full Text] [Related]
76. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
77. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
[TBL] [Abstract][Full Text] [Related]
78. [The molecular mechanism of antiapoptosis of type II alveolar epithelial cell by microRNA-21-5p].
Qin S; Chen M; Ji H; Liu G; Chen T; Li K; Mei H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jul; 27(7):574-8. PubMed ID: 26138419
[TBL] [Abstract][Full Text] [Related]
79. Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
Montero-Conde C; Graña-Castro O; Martín-Serrano G; Martínez-Montes ÁM; Zarzuela E; Muñoz J; Torres-Perez R; Pita G; Cordero-Barreal A; Leandro-García LJ; Letón R; López de Silanes I; Guadalix S; Pérez-Barrios A; Hawkins F; Guerrero-Álvarez A; Álvarez-Escolá C; Regojo-Zapata RM; Calsina B; Remacha L; Roldán-Romero JM; Santos M; Lanillos J; Jordá M; Riesco-Eizaguirre G; Zafon C; González-Neira A; Blasco MA; Al-Shahrour F; Rodríguez-Antona C; Cascón A; Robledo M
Int J Cancer; 2020 Jan; 146(2):521-530. PubMed ID: 31403184
[TBL] [Abstract][Full Text] [Related]
80. Dysregulation of miR-551b-5p and
Dong A; Gao M; Zheng X; Ruan X
Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1400-1409. PubMed ID: 37073141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
